Contact
Header_1077x260px_About_Profil.jpg

Addressing postprandial glucose excursion – What is the evidence?

Walking the GIR-smoothing tightrope – data refinement versus data impairment

Profil congratulates Senseonics on CE Mark for 90-day implantable CGM sensor

The New Clinical Trials Regulation EU No 536/2014 - Update (02/2017)

What does a CRA do at Profil?

Ever considered becoming a research physician at a CRO?

Choosing markers of glycemic control during clinical trial design

Understanding Insulin Resistance   (Part 2)

Understanding Insulin Resistance   (Part 1)

Impressions of Roche Diabetes #social media dialogue 2016